Guided Therapeutics (GTHP) Interest Coverage Ratio (2016 - 2025)
Historic Interest Coverage Ratio for Guided Therapeutics (GTHP) over the last 16 years, with Q3 2025 value amounting to 3.76.
- Guided Therapeutics' Interest Coverage Ratio rose 2762.09% to 3.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 3.87, marking a year-over-year increase of 4002.47%. This contributed to the annual value of 5.53 for FY2024, which is 5550.71% up from last year.
- Guided Therapeutics' Interest Coverage Ratio amounted to 3.76 in Q3 2025, which was up 2762.09% from 4.86 recorded in Q2 2025.
- In the past 5 years, Guided Therapeutics' Interest Coverage Ratio registered a high of 0.82 during Q3 2021, and its lowest value of 21.81 during Q2 2023.
- In the last 5 years, Guided Therapeutics' Interest Coverage Ratio had a median value of 5.19 in 2024 and averaged 6.66.
- In the last 5 years, Guided Therapeutics' Interest Coverage Ratio tumbled by 86317.94% in 2022 and then surged by 5996.01% in 2024.
- Quarter analysis of 5 years shows Guided Therapeutics' Interest Coverage Ratio stood at 4.35 in 2021, then plummeted by 211.33% to 13.54 in 2022, then skyrocketed by 50.26% to 6.74 in 2023, then soared by 40.84% to 3.99 in 2024, then rose by 5.66% to 3.76 in 2025.
- Its Interest Coverage Ratio stands at 3.76 for Q3 2025, versus 4.86 for Q2 2025 and 2.82 for Q1 2025.